The improved clinical course of persistent tachypnea of infancy with inhaled bronchodilators and corticosteroids
Pediatric Pulmonology2021Vol. 56(12), pp. 3952–3959
Citations Over TimeTop 20% of 2021 papers
Honorata Marczak, Joanna Peradzyńska, Elias Seidl, Matthias Griese, Tomasz Urbankowski, Joanna Lange, Stanisław Bogusławski, Katarzyna Krenke
Abstract
Inhaled bronchodilators and ICS may exert a positive effect on the severity of symptoms and pulmonary function test (PFT) in symptomatic children with PTI. However, a randomized control trial should be conducted to confirm their effectiveness.
Related Papers
- → Can We Predict Which Children With Clinically Suspected Pneumonia Will Have the Presence of Focal Infiltrates on Chest Radiographs?(2004)127 cited
- → Effects of socioeconomic status on presentation with acute lower respiratory tract disease in children in Salvador, Northeast Brazil(2002)36 cited
- → [Clinical features of neuroendocrine cell hyperplasia of infancy].(2020)4 cited
- → Case 37-2011(2011)4 cited
- → Neuroendocrine cell hyperplasia (NEHI) and NEHI Syndrome: Lung biopsy necessary?(2014)